ImageneBio, Inc. — Director's Dealing 2025

Dec 22, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ImageneBio, Inc. (IMA)
CIK: 0001835579
Period of Report: 2025-12-18

Reporting Person: Wang Stephen Hui (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-12-18	Employee Stock Option (Right to Buy)	$6.19	A	31200	Acquired	2035-12-18	Common Stock (31200)	Direct

Footnotes

F1: The award was granted as an Initial Grant as contemplated by the non-employee director compensation policy adopted by the Issuer's board of directors on December 18, 2025.

F2: This option vests over a three-year period, with 1/36th of the shares subject to the option vesting in 36 substantially equal monthly installments, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan) through each such date.